Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc.（RNAC）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · RNAC · 截至 2026年6月8日
活动摘要
买入笔数
17
P-Purchase only
卖出笔数
15
近12个月
买卖比
1.13
Buy/Sell (by trades)
整体情绪
Cartesian Therapeutics, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
RNAC 季度内部人买卖趋势
RNAC 内幕交易卖出 · RNAC 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · RNAC CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
RNAC 高管卖出股份 · RNAC 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 2, 2026 | Hoge Elizabeth 10 percent owner | Option | 758,001 | — | Form 4 |
| Apr 2, 2026 | Kalayoglu Murat 10 percent owner | Option | 758,001 | — | Form 4 |
| Jan 6, 2026 | Brunn Carsten President and CEO · Director | Sale | 23,766 | $162K | Form 4 |
| Jan 2, 2026 | DeSilva Nishan M Director | Award | 2,600 | — | Form 4 |
| Jan 2, 2026 | Brunn Carsten President and CEO · Director | Award | 143,200 | — | Form 4 |
| Jan 2, 2026 | ZENNER PATRICK J Director | Award | 2,600 | — | Form 4 |
| Jan 2, 2026 | BARABE TIMOTHY C Director | Award | 2,600 | — | Form 4 |
| Jan 2, 2026 | SPRINGER TIMOTHY A Director | Award | 2,600 | — | Form 4 |
| Dec 4, 2025 | BARABE TIMOTHY C Director | Purchase | 30,000 | $206K | Form 4 |
| Apr 11, 2025 | SPRINGER TIMOTHY A Director | Purchase | 6,412 | $69K | Form 4 |
| Apr 10, 2025 | SPRINGER TIMOTHY A Director | Purchase | 609 | $7K | Form 4 |
| Apr 10, 2025 | SPRINGER TIMOTHY A Director | Purchase | 7,966 | $83K | Form 4 |
| Apr 9, 2025 | SPRINGER TIMOTHY A Director | Purchase | 31 | $308 | Form 4 |
| Apr 9, 2025 | SPRINGER TIMOTHY A Director | Purchase | 7,342 | $69K | Form 4 |
| Apr 11, 2025 | SPRINGER TIMOTHY A Director | Purchase | 36,338 | $391K | Form 4 |
| Apr 10, 2025 | SPRINGER TIMOTHY A Director | Purchase | 3,451 | $38K | Form 4 |
| Apr 10, 2025 | SPRINGER TIMOTHY A Director | Purchase | 45,144 | $471K | Form 4 |
| Apr 9, 2025 | SPRINGER TIMOTHY A Director | Purchase | 178 | $2K | Form 4 |
| Apr 9, 2025 | SPRINGER TIMOTHY A Director | Purchase | 41,604 | $392K | Form 4 |
| Mar 20, 2025 | SPRINGER TIMOTHY A Director | Purchase | 54,889 | $856K | Form 4 |
| Mar 19, 2025 | SPRINGER TIMOTHY A Director | Purchase | 20,234 | $303K | Form 4 |
| Mar 18, 2025 | SPRINGER TIMOTHY A Director | Purchase | 14,740 | $213K | Form 4 |
| Jan 14, 2025 | SPRINGER TIMOTHY A Director | Purchase | 4,022 | $72K | Form 4 |
| Jan 13, 2025 | SPRINGER TIMOTHY A Director | Purchase | 8,983 | $160K | Form 4 |
| Jan 13, 2025 | SPRINGER TIMOTHY A Director | Purchase | 7,962 | $134K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 RNAC 内幕交易
RNAC 内幕交易
Cartesian Therapeutics, Inc.（RNAC）内幕交易数据来源于公司内部人（包括Brunn Carsten (President and CEO · Director), BARABE TIMOTHY C (Director), Hoge Elizabeth (10 percent owner)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。RNAC内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cartesian Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
RNAC 内幕交易 · 5个问题Cartesian Therapeutics, Inc.（RNAC）的内部人包括高管和董事，如Brunn Carsten (President and CEO · Director), BARABE TIMOTHY C (Director), Hoge Elizabeth (10 percent owner)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026